Lifestyle, Reproduction and Cancer, Danish Cancer Society Research Center, Copenhagen, Denmark.
Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark; Department of Gynecology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Fertil Steril. 2022 Oct;118(4):738-747. doi: 10.1016/j.fertnstert.2022.06.029. Epub 2022 Aug 28.
To study the association between use of fertility drugs and colorectal cancer among women with infertility.
Population-based cohort study.
Not applicable.
PATIENT(S): The study cohort was obtained from the Danish Infertility Cohort and consisted of all women with infertility aged 20-45 years living in Denmark during 1995-2017.
INTERVENTION(S): Information on the use of specific types of fertility drugs, colorectal cancer diagnoses, covariates, and vital status were obtained from the Danish Infertility Cohort and Danish national registers.
MAIN OUTCOME MEASURE(S): Cox proportional hazard models adjusted for potential confounders were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) for colorectal cancer overall and rectal and colon cancer separately.
RESULTS(S): Among 148,036 women in the final study cohort, 205 women were diagnosed with colorectal cancer. Ever use of clomiphene citrate (CC) was associated with a lower rate of colorectal cancer (unadjusted HR, 0.67; 95% CI, 0.51-0.89; adjusted HR, 0.68; 95% CI, 0.50-0.93). However, the lower rate was only seen among women who first used CC >8 years ago (unadjusted HR, 0.56; 95% CI, 0.41-0.76; adjusted HR, 0.52; 95% CI, 0.36-0.75). No marked associations were found between the use of any of other types of fertility drugs and colorectal cancer. The results for colon and rectal cancer analyzed separately were similar, except for a suggestion of a decreased risk of rectal cancer associated with the use of gonadotropins (adjusted HR, 0.46; 95% CI, 0.20-1.08).
CONCLUSION(S): Among women with infertility, the use of most types of fertility drugs was not associated with colorectal cancer. However, CC may decrease the risk of colorectal cancer and gonadotropins might decrease the risk of rectal cancer, but we cannot rule out that these findings may be more related to the underlying conditions in these women or are chance findings. Consequently, the results from this study should be investigated further in large epidemiological studies.
研究不孕症女性使用生育药物与结直肠癌之间的关联。
基于人群的队列研究。
不适用。
研究队列来自丹麦不孕症队列,包括 1995 年至 2017 年期间在丹麦居住的年龄在 20-45 岁之间的所有不孕症女性。
通过丹麦不孕症队列和丹麦国家登记处获取特定类型生育药物使用情况、结直肠癌诊断、协变量和生存状态信息。
使用 Cox 比例风险模型调整潜在混杂因素,以估计总体结直肠癌以及直肠和结肠癌的风险比(HR)和 95%置信区间(CI)。
在最终研究队列的 148036 名女性中,有 205 名被诊断患有结直肠癌。使用枸橼酸氯米酚(CC)的女性结直肠癌发生率较低(未调整 HR,0.67;95%CI,0.51-0.89;调整 HR,0.68;95%CI,0.50-0.93)。然而,仅在首次使用 CC >8 年前的女性中观察到这种低发生率(未调整 HR,0.56;95%CI,0.41-0.76;调整 HR,0.52;95%CI,0.36-0.75)。使用其他任何类型生育药物与结直肠癌之间均无明显关联。单独分析结肠癌和直肠癌的结果相似,但促性腺激素的使用与直肠癌风险降低有关(调整 HR,0.46;95%CI,0.20-1.08)。
在不孕症女性中,大多数类型的生育药物的使用与结直肠癌无关。然而,CC 可能降低结直肠癌的风险,促性腺激素可能降低直肠癌的风险,但我们不能排除这些发现可能与这些女性的潜在疾病更相关,或者是偶然发现。因此,这些研究结果应在大型流行病学研究中进一步研究。